Clinical Trial Update: Therapeutic Equivalence Trial of Two Hormonal-IUDs in Patients With Heavy Menstrual Bleeding [Phase 3]

View source ↗

Summary

Phase 3 therapeutic equivalence trial comparing two hormonal intrauterine devices for heavy menstrual bleeding has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heavy Menstrual Bleeding

Drugs mentioned

• Hormonal intrauterine device A
• Hormonal intrauterine device B

Snippet

Sponsor: Uteron Pharma S.A. | Conditions: Heavy Menstrual Bleeding | Phase 3 | Status: COMPLETED